Gelsolin and diseases

Subcellular Biochemistry

Volumn 45, Issue , 2007, Pages 55-69

  Spinardi, Laura ^a   Witke, W ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b EUROPEAN MOLECULAR BIOLOGY LABORATORY EMBL   (Italy)

Author keywords

Amyloidosis; Calcium; Cancer; Diseases; Gelsolin; Inflammation

Indexed keywords

ACTIN; CALCIUM; GELSOLIN; PHOSPHATIDYLINOSITOL;

AMYLOIDOSIS; ANIMAL; GENETICS; HUMAN; INFLAMMATION; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; TUMOR SUPPRESSOR GENE;

ACTINS; AMYLOIDOSIS; ANIMALS; CALCIUM; GELSOLIN; GENES, TUMOR SUPPRESSOR; HUMANS; INFLAMMATION; PHOSPHATIDYLINOSITOLS;

EID: 38849088197     PISSN: 03060225     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4020-6191-2_3     Document Type: Article

References (105)

1. Aidinis, V., P. Carninci, M. Armaka, W. Witke, V. Harokopos, N. Pavelka, D. Koczan, C. Argyropoulos, M.M. Thwin, S. Moller, K. Waki, P. Gopalakrishnakone, P. Ricciardi-Castagnoli, H.J. Thiesen, Y. Hayashizaki, and G. Kollias. 2005. Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis. PLoS Genet. 1:e48.
2. Allen, P.G. 2003. Actin filament uncapping localizes to ruffling lamellae and rocketing vesicles. Nat Cell Biol. 5:972-9.
3. Arai, M., and D.J. Kwiatkowski. 1999. Differential developmentally regulated expression of gelsolin family members in the mouse. Dev Dyn. 215:297-307.
4. Arcaro, A. 1998. The small GTP-binding protein Rac promotes the dissociation of gelsolin from actin filaments in neutrophils. J Biol Chem. 273:805-13.
5. Aridor, M., and W.E. Balch. 1999. Integration of endoplasmic reticulum signaling in health and disease. Nat Med. 5:745-51.
6. Arora, P.D., M. Glogauer, A. Kapus, D.J. Kwiatkowski, and C.A. McCulloch. 2004. Gelsolin mediates collagen phagocytosis through a rac-dependent step. Mol Biol Cell. 15:588-99.
7. Arora, P.D., P.A. Janmey, and C.A. McCulloch. 1999. A role for gelsolin in stress fiber-dependent cell contraction. Exp Cell Res. 250:155-67.
8. Asch, H.L., K. Head, Y. Dong, F. Natoli, J.S. Winston, J.L. Connolly, and B.B. Asch. 1996. Widespread loss of gelsolin in breast cancers of humans, mice, and rats. Cancer Res. 56:4841-5.
9. Asch, H.L., J.S. Winston, S.B. Edge, P.C. Stomper, and B.B. Asch. 1999. Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion. Breast Cancer Res Treat. 55:179-88.
10. Azuma, T., W. Witke, T.P. Stossel, J.H. Hartwig, and D.J. Kwiatkowski. 1998. Gelsolin is a downstream effector of rac for fibroblast motility. Embo J. 17:1362-70.
11. Barkalow, K., W. Witke, D.J. Kwiatkowski, and J.H. Hartwig. 1996. Coordinated regulation of platelet actin filament barbed ends by gelsolin and capping protein. J Cell Biol. 134:389-99.
12. Bretscher, A., and K. Weber. 1979. Villin: the major microfilament-associated protein of the intestinal microvillus. Proc Natl Acad Sci U S A. 76:2321-5.
13. Bretscher, A., and K. Weber. 1980. Villin is a major protein of the microvillus cytoskeleton which binds both G and F actin in a calcium-dependent manner. Cell. 20:839-47.
14. Bryan, J. 1988. Gelsolin has three actin-binding sites. J Cell Biol. 106:1553-62.
15. 2+ regulatory domain in human brevin. J Cell Biol. 102:1439-46.
16. Burtnick, L.D., E.K. Koepf, J. Grimes, E.Y. Jones, D.I. Stuart, P.J. McLaughlin, and R.C. Robinson. 1997. The crystal structure of plasma gelsolin: implications for actin severing, capping, and nucleation. Cell. 90:661-70.
17. Burtnick, L.D., D. Urosev, E. Irobi, K. Narayan, and R.C. Robinson. 2004. Structure of the N-terminal half of gelsolin bound to actin: roles in severing, apoptosis and FAF. Embo J. 23:2713-22.
18. Campbell, H.D., T. Schimansky, C. Claudianos, N. Ozsarac, A.B. Kasprzak, J.N. Cotsell, I.G. Young, H.G. de Couet, and G.L. Miklos. 1993. The Drosophila melanogaster flightless-I gene involved in gastrulation and muscle degeneration encodes gelsolin-like and leucine-rich repeat domains and is conserved in Caenorhabditis elegans and humans. Proc Natl Acad Sci U S A. 90:11386-90.
19. Carlier, M.F. 1998. Control of actin dynamics. Curr Opin Cell Biol. 10:45-51.
20. Caron, E., and A. Hall. 1998. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science. 282:1717-21.
21. Carrell, R.W., and B. Gooptu. 1998. Conformational changes and disease-serpins, prions and Alzheimer's. Curr Opin Struct Biol. 8:799-809.
22. Chaponnier, C., P.A. Janmey, and H.L. Yin. 1986. The actin filament-severing domain of plasma gelsolin. J Cell Biol. 103:1473-81.
23. Chen, C.D., M.E. Huff, J. Matteson, L. Page, R. Phillips, J.W. Kelly, and W.E. Balch. 2001. Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca(2+) stabilization. Embo J. 20:6277-87.
24. Choe, H., L.D. Burtnick, M. Mejillano, H.L. Yin, R.C. Robinson, and S. Choe. 2002. The calcium activation of gelsolin: insights from the 3A structure of the G4-G6/actin complex. J Mol Biol. 324:691-702.
25. Cunningham, C.C., T.P. Stossel, and D.J. Kwiatkowski. 1991. Enhanced motility in NIH 3T3 fibroblasts that overexpress gelsolin. Science. 251:1233-6.
26. Dabiri, G.A., C.L. Young, J. Rosenbloom, and F.S. Southwick. 1992. Molecular cloning of human macrophage capping protein cDNA. A unique member of the gelsolin/villin family expressed primarily in macrophages. J Biol Chem. 267:16545-52.
27. Dahl, B., F.V. Schiodt, P. Ott, R. Gvozdenovic, H.L. Yin, and W.M. Lee. 1999. Plasma gelsolin is reduced in trauma patients. Shock. 12:102-4.
28. Davoodian, K., B.W. Ritchings, R. Ramphal, and M.R. Bubb. 1997. Gelsolin activates DNase I in vitro and cystic fibrosis sputum. Biochemistry. 36:9637-41.
29. De Corte, V., E. Bruyneel, C. Boucherie, M. Mareel, J. Vandekerckhove, and J. Gettemans. 2002. Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling. Embo J. 21:6781-90.
30. Dosaka-Akita, H., F. Hommura, H. Fujita, I. Kinoshita, M. Nishi, T. Morikawa, H. Katoh, Y. Kawakami, and N. Kuzumaki. 1998. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers. Cancer Res. 58:322-7.
31. Ehrlich, H.P., G.M. Allison, M.J. Page, W.A. Kolton, and M. Graham. 2000. Increased gelsolin expression and retarded collagen lattice contraction with smooth muscle cells from Crohn's diseased intestine. J Cell Physiol. 182:303-9.
32. Fishkind, D.J., and Y.L. Wang. 1995. New horizons for cytokinesis. Curr Opin Cell Biol. 7:23-31.
33. Fujita, H., F. Okada, J. Hamada, M. Hosokawa, T. Moriuchi, R.C. Koya, and N. Kuzumaki. 2001. Gelsolin functions as a metastasis suppressor in B16-BL6 mouse melanoma cells and requirement of the carboxyl-terminus for its effect. Int J Cancer. 93:773-80.
34. Furukawa, K., W. Fu, Y. Li, W. Witke, D.J. Kwiatkowski, and M.P. Mattson. 1997. The actin-severing protein gelsolin modulates calcium channel and NMDA receptor activities and vulnerability to excitotoxicity in hippocampal neurons. J Neurosci. 17:8178-86.
35. Goshima, M., K. Kariya, Y. Yamawaki-Kataoka, T. Okada, M. Shibatohge, F. Shima, E. Fujimoto, and T. Kataoka. 1999. Characterization of a novel Ras-binding protein Ce-FLI-1 comprising leucine-rich repeats and gelsolin-like domains. Biochem Biophys Res Commun. 257:111-6.
36. Hatanaka, H., K. Ogura, K. Moriyama, S. Ichikawa, I. Yahara, and F. Inagaki. 1996. Tertiary structure of destrin and structural similarity between two actin-regulating protein families. Cell. 85:1047-55.
37. 2+ affinity determines susceptibility to furin proteolysis and familial amyloidosis of finnish type. J Mol Biol. 334:119-27.
38. Isaacson, R.L., A.G. Weeds, and A.R. Fersht. 1999. Equilibria and kinetics of folding of gelsolin domain 2 and mutants involved in familial amyloidosis-Finnish type. Proc Natl Acad Sci U S A. 96:11247-52.
39. Ismailov, II, B.K. Berdiev, V.G. Shlyonsky, C.M. Fuller, A.G. Prat, B. Jovov, H.F. Cantiello, D.A. Ausiello, and D.J. Benos. 1997. Role of actin in regulation of epithelial sodium channels by CFTR. Am J Physiol. 272:C1077-86.
40. Janmey, P.A., K. Iida, H.L. Yin, and T.P. Stossel. 1987. Polyphosphoinositide micelles and polyphosphoinositide-containing vesicles dissociate endogenous gelsolin-actin complexes and promote actin assembly from the fast-growing end of actin filaments blocked by gelsolin. J Biol Chem. 262:12228-36.
41. Janmey, P.A., T.P. Stossel, and S.E. Lind. 1986. Sequential binding of actin monomers to plasma gelsolin and its inhibition by vitamin D-binding protein. Biochem Biophys Res Commun. 136:72-9.
42. Kamada, S., H. Kusano, H. Fujita, M. Ohtsu, R.C. Koya, N. Kuzumaki, and Y. Tsujimoto. 1998. A cloning method for caspase substrates that uses the yeast two-hybrid system: cloning of the antiapoptotic gene gelsolin. Proc Natl Acad Sci U S A. 95:8532-7.
43. Kangas, H., I. Ulmanen, T. Paunio, D.J. Kwiatkowski, M. Lehtovirta, A. Jalanko, and L. Peltonen. 1999. Functional consequences of amyloidosis mutation for gelsolin polypeptide - analysis of gelsolin-actin interaction and gelsolin processing in gelsolin knock-out fibroblasts. FEBS Lett. 454:233-9.
44. Kelly, J.W. 1996. Alternative conformations of amyloidogenic proteins govern their behavior. Curr Opin Struct Biol. 6:11-7.
45. Kothakota, S., T. Azuma, C. Reinhard, A. Klippel, J. Tang, K. Chu, T.J. McGarry, M.W. Kirschner, K. Koths, D.J. Kwiatkowski, and L.T. Williams. 1997. Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis. Science. 278:294-8.
46. Kuzumaki, N., M. Tanaka, N. Sakai, and H. Fujita. 1997. [Tumor suppressive function of gelsolin]. Gan To Kagaku Ryoho. 24:1436-41.
47. Kwiatkowski, D.J. 1999. Functions of gelsolin: motility, signaling, apoptosis, cancer. Curr Opin Cell Biol. 11:103-8.
48. Kwiatkowski, D.J., P.A. Janmey, J.E. Mole, and H.L. Yin. 1985. Isolation and properties of two actinbinding domains in gelsolin. J Biol Chem. 260:15232-8.
49. Kwiatkowski, D.J., P.A. Janmey, and H.L. Yin. 1989. Identification of critical functional and regulatory domains in gelsolin. J Cell Biol. 108:1717-26.
50. Kwiatkowski, D.J., R. Mehl, S. Izumo, B. Nadal-Ginard, and H.L. Yin. 1988. Muscle is the major source of plasma gelsolin. J Biol Chem. 263:8239-43.
51. Kwiatkowski, D.J., T.P. Stossel, S.H. Orkin, J.E. Mole, H.R. Colten, and H.L. Yin. 1986. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature. 323:455-8.
52. Lu, M., W. Witke, D.J. Kwiatkowski, and K.S. Kosik. 1997. Delayed retraction of filopodia in gelsolin null mice. J Cell Biol. 138:1279-87.
53. Lueck, A., D. Brown, and D.J. Kwiatkowski. 1998. The actin-binding proteins adseverin and gelsolin are both highly expressed but differentially localized in kidney and intestine. J Cell Sci. 111 (Pt 24): 3633-43.
54. Maekawa, S., and H. Sakai. 1990. Inhibition of actin regulatory activity of the 74-kDa protein from bovine adrenal medulla (adseverin) by some phospholipids. J Biol Chem. 265:10940-2.
55. Maury, C.P. 1991. Gelsolin-related amyloidosis. Identification of the amyloid protein in Finnish hereditary amyloidosis as a fragment of variant gelsolin. J Clin Invest. 87:1195-9.
56. Maury, C.P., M. Liljestrom, G. Boysen, T. Tornroth, A. de la Chapelle, and E.L. Nurmiaho-Lassila. 2000. Danish type gelsolin related amyloidosis: 654G-T mutation is associated with a disease pathogenetically and clinically similar to that caused by the 654G-A mutation (familial amyloidosis of the Finnish type). J Clin Pathol. 53:95-9.
57. Maury, C.P., M. Liljestrom, S. Tiitinen, K. Laiho, K. Kaarela, and C. Ehnholm. 2001. Apolipoprotein E phenotypes in rheumatoid arthritis with or without amyloidosis. Amyloid. 8:270-3.
58. Mayadas, T.N., R.C. Johnson, H. Rayburn, R.O. Hynes, and D.D. Wagner. 1993. Leukocyte rolling and extravasation are severely compromised in P selectin-deficient mice. Cell. 74:541-54.
59. McGough, A., W. Chiu, and M. Way. 1998. Determination of the gelsolin binding site on F-actin: implications for severing and capping. Biophys J. 74:764-72.
60. McGough, A.M., C.J. Staiger, J.K. Min, and K.D. Simonetti. 2003. The gelsolin family of actin regulatory proteins: modular structures, versatile functions. FEBS Lett. 552:75-81.
61. McLaughlin, P.J., J.T. Gooch, H.G. Mannherz, and A.G. Weeds. 1993. Structure of gelsolin segment 1-actin complex and the mechanism of filament severing. Nature. 364:685-92.
62. Mielnicki, L.M., A.M. Ying, K.L. Head, H.L. Asch, and B.B. Asch. 1999. Epigenetic regulation of gelsolin expression in human breast cancer cells. Exp Cell Res. 249:161-76.
63. Mullauer, L., H. Fujita, A. Ishizaki, and N. Kuzumaki. 1993. Tumor-suppressive function of mutated gelsolin in ras-transformed cells. Oncogene. 8:2531-6.
64. Onda, H., A. Lueck, P.W. Marks, H.B. Warren, and D.J. Kwiatkowski. 1999. Tsc2(+/-) mice develop tumors in multiple sites that express gelsolin and are influenced by genetic background. J Clin Invest. 104:687-95.
65. 2+ binding protects against gelsolin amyloidosis. Biochem Biophys Res Commun. 322:1105-10.
66. Paunio, T., H. Kangas, O. Heinonen, M.H. Buc-Caron, J.J. Robert, S. Kaasinen, I. Julkunen, J. Mallet, and L. Peltonen. 1998. Cells of the neuronal lineage play a major role in the generation of amyloid precursor fragments in gelsolin-related amyloidosis. J Biol Chem. 273:16319-24.
67. Pollard, T.D., and J.A. Cooper. 1986. Actin and actin-binding proteins. A critical evaluation of mechanisms and functions. Annu Rev Biochem. 55:987-1035.
68. Pope, B., S. Maciver, and A. Weeds. 1995. Localization of the calcium-sensitive actin monomer binding site in gelsolin to segment 4 and identification of calcium binding sites. Biochemistry. 34:1583-8.
69. Pope, B., M. Way, and A.G. Weeds. 1991. Two of the three actin-binding domains of gelsolin bind to the same subdomain of actin. Implications of capping and severing mechanisms. FEBS Lett. 280:70-4.
70. Prasad, S.C., P.J. Thraves, A. Dritschilo, and M.R. Kuettel. 1997. Protein expression changes associated with radiation-induced neoplastic progression of human prostate epithelial cells. Electrophoresis. 18:629-37.
71. Prendergast, G.C., and E.B. Ziff. 1991. Mbh 1: a novel gelsolin/severin-related protein which binds actin in vitro and exhibits nuclear localization in vivo. Embo J. 10:757-66.
72. Rodriguez Del Castillo, A., S. Lemaire, L. Tchakarov, M. Jeyapragasan, J.P. Doucet, M.L. Vitale, and J.M. Trifaro. 1990. Chromaffin cell scinderin, a novel calcium-dependent actin filament-severing protein. Embo J. 9:43-52.
73. Rothenbach, P.A., B. Dahl, J.J. Schwartz, G.E. O'Keefe, M. Yamamoto, W.M. Lee, J.W. Horton, H.L. Yin, and R.H. Turnage. 2004. Recombinant plasma gelsolin infusion attenuates burn-induced pulmonary microvascular dysfunction. J Appl Physiol. 96:25-31.
74. Sagawa, N., H. Fujita, Y. Banno, Y. Nozawa, H. Katoh, and N. Kuzumaki. 2003. Gelsolin suppresses tumorigenicity through inhibiting PKC activation in a human lung cancer cell line, PC10. Br J Cancer. 88:606-12.
75. Selden, L.A., H.J. Kinosian, J. Newman, B. Lincoln, C. Hurwitz, L.C. Gershman, and J.E. Estes. 1998. Severing of F-actin by the amino-terminal half of gelsolin suggests internal cooperativity in gelsolin. Biophys J. 75:3092-100.
76. Serrander, L., P. Skarman, B. Rasmussen, W. Witke, D.P. Lew, K.H. Krause, O. Stendahl, and O. Nusse. 2000. Selective inhibition of IgG-mediated phagocytosis in gelsolin-deficient murine neutrophils. J Immunol. 165:2451-7.
77. Sheils, C.A., J. Kas, W. Travassos, P.G. Allen, P.A. Janmey, M.E. Wohl, and T.P. Stossel. 1996. Actin filaments mediate DNA fiber formation in chronic inflammatory airway disease. Am J Pathol. 148:919-27.
78. Shieh, D.B., J. Godleski, J.E. Herndon, 2nd, T. Azuma, H. Mercer, D.J. Sugarbaker, and D.J. Kwiatkowski. 1999. Cell motility as a prognostic factor in Stage I nonsmall cell lung carcinoma: the role of gelsolin expression. Cancer. 85:47-57.
79. 2+-sensitive, 41,000-dalton protein which reversibly blocks the "barbed" ends of actin filaments but does not sever them. J Biol Chem. 261:14191-5.
80. Suhler, E., W. Lin, H.L. Yin, and W.M. Lee. 1997. Decreased plasma gelsolin concentrations in acute liver failure, myocardial infarction, septic shock, and myonecrosis. Crit Care Med. 25:594-8.
81. Sun, H.Q., M. Yamamoto, M. Mejillano, and H.L. Yin. 1999. Gelsolin, a multifunctional actin regulatory protein. J Biol Chem. 274:33179-82.
82. Tanaka, J., and K. Sobue. 1994. Localization and characterization of gelsolin in nervous tissues: gelsolin is specifically enriched in myelin-forming cells. J Neurosci. 14:1038-52.
83. Tanaka, M., L. Mullauer, Y. Ogiso, H. Fujita, S. Moriya, K. Furuuchi, T. Harabayashi, N. Shinohara, T. Koyanagi, and N. Kuzumaki. 1995. Gelsolin: a candidate for suppressor of human bladder cancer. Cancer Res. 55:3228-32.
84. Teubner, A., I. Sobek-Klocke, H. Hinssen, and U. Eichenlaub-Ritter. 1994. Distribution of gelsolin in mouse ovary. Cell Tissue Res. 276:535-44.
85. Thor, A.D., S.M. Edgerton, S. Liu, D.H. Moore, 2nd, and D.J. Kwiatkowski. 2001. Gelsolin as a negative prognostic factor and effector of motility in erbB-2-positive epidermal growth factor receptor-positive breast cancers. Clin Cancer Res. 7:2415-24.
86. Vasconcellos, C.A., P.G. Allen, M.E. Wohl, J.M. Drazen, P.A. Janmey, and T.P. Stossel. 1994. Reduction in viscosity of cystic fibrosis sputum in vitro by gelsolin. Science. 263:969-71.
87. Vouyiouklis, D.A., and P.J. Brophy. 1997. A novel gelsolin isoform expressed by oligodendrocytes in the central nervous system. J Neurochem. 69:995-1005.
88. Wagner, E.F., and R. Eferl. 2005. Fos/AP-1 proteins in bone and the immune system. Immunol Rev. 208:126-40.
89. Way, M., and P. Matsudaira. 1993. The secrets of severing? Curr Biol. 3:887-90.
90. Way, M., B. Pope, J. Gooch, M. Hawkins, and A.G. Weeds. 1990. Identification of a region in segment 1 of gelsolin critical for actin binding. Embo J. 9:4103-9.
91. Way, M., B. Pope, and A. Weeds. 1991. Molecular biology of actin binding proteins: evidence for a common structural domain in the F-actin binding sites of gelsolin and alpha-actinin. J Cell Sci Suppl. 14:91-4.
92. Way, M., B. Pope, and A.G. Weeds. 1992. Are the conserved sequences in segment 1 of gelsolin important for binding actin? J Cell Biol. 116:1135-43.
93. Weeds, A.G., J. Gooch, P. McLaughlin, and C.P. Maury. 1993. Variant plasma gelsolin responsible for familial amyloidosis (Finnish type) has defective actin severing activity. FEBS Lett. 335:119-23.
94. Weeds, A.G., J. Gooch, P. McLaughlin, B. Pope, M. Bengtsdotter, and R. Karlsson. 1995. Identification of the trapped calcium in the gelsolin segment 1-actin complex: implications for the role of calcium in the control of gelsolin activity. FEBS Lett. 360:227-30.
95. Wegner, A. 1976. Head to tail polymerization of actin. J Mol Biol. 108:139-50.
96. Welch, M.D., A. Mallavarapu, J. Rosenblatt, and T.J. Mitchison. 1997. Actin dynamics in vivo. Curr Opin Cell Biol. 9:54-61.
97. Witke, W., W. Li, D.J. Kwiatkowski, and F.S. Southwick. 2001. Comparisons of CapG and gelsolin-null macrophages: demonstration of a unique role for CapG in receptor-mediated ruffling, phagocytosis, and vesicle rocketing. J Cell Biol. 154:775-84.
98. Witke, W., A.H. Sharpe, J.H. Hartwig, T. Azuma, T.P. Stossel, and P. Chang. 1995. Hemostatic, inflammatory, and fibroblast responses are blunted in mice lacking gelsolin. Cell. 81:41-51.
99. Yamada, K.M., and B. Geiger. 1997. Molecular interactions in cell adhesion complexes. Curr Opin Cell Biol. 9:76-85.
100. Yin, H.L., D.J. Kwiatkowski, J.E. Mole, and F.S. Cole. 1984. Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem. 259:5271-6.
101. Yin, H.L., and T.P. Stossel. 1979. Control of cytoplasmic actin gel-sol transformation by gelsolin, a calcium-dependent regulatory protein. Nature. 281:583-6.
102. Yin, H.L., and J.T. Stull. 1999. Proteins that regulate dynamic actin remodeling in response to membrane signaling minireview series. J Biol Chem. 274:32529-30.
103. 2+ control of actin gelation. Interaction of gelsolin with actin filaments and regulation of actin gelation. J Biol Chem. 255:9494-500.
104. Yu, F.X., P.A. Johnston, T.C. Sudhof, and H.L. Yin. 1990. gCap39, a calcium ion- and polyphosphoinositide-regulated actin capping protein. Science. 250:1413-5.
105. Zerovnik, E. 2002. Amyloid-fibril formation. Proposed mechanisms and relevance to conformational disease. Eur J Biochem. 269:3362-71.